Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2004 1
2005 6
2006 8
2007 9
2008 5
2009 3
2010 2
2011 4
2012 6
2013 4
2015 1
2016 2
2017 1
2018 3
2020 1
2021 3
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
Oligosarcomas, IDH-mutant are distinct and aggressive.
Suwala AK, Felix M, Friedel D, Stichel D, Schrimpf D, Hinz F, Hewer E, Schweizer L, Dohmen H, Pohl U, Staszewski O, Korshunov A, Stein M, Wongsurawat T, Cheunsuacchon P, Sathornsumetee S, Koelsche C, Turner C, Le Rhun E, Mühlebner A, Schucht P, Özduman K, Ono T, Shimizu H, Prinz M, Acker T, Herold-Mende C, Kessler T, Wick W, Capper D, Wesseling P, Sahm F, von Deimling A, Hartmann C, Reuss DE. Suwala AK, et al. Among authors: sathornsumetee s. Acta Neuropathol. 2022 Feb;143(2):263-281. doi: 10.1007/s00401-021-02395-z. Epub 2021 Dec 30. Acta Neuropathol. 2022. PMID: 34967922 Free PMC article.
Molecularly targeted therapy in neuro-oncology.
Sathornsumetee S, Rich JN. Sathornsumetee S, et al. Handb Clin Neurol. 2012;104:255-78. doi: 10.1016/B978-0-444-52138-5.00018-9. Handb Clin Neurol. 2012. PMID: 22230448 Review. No abstract available.
Twisted tango: brain tumor neurovascular interactions.
Hjelmeland AB, Lathia JD, Sathornsumetee S, Rich JN. Hjelmeland AB, et al. Among authors: sathornsumetee s. Nat Neurosci. 2011 Oct 26;14(11):1375-81. doi: 10.1038/nn.2955. Nat Neurosci. 2011. PMID: 22030548 Free PMC article. Review.
Diagnosis and treatment of high-grade astrocytoma.
Sathornsumetee S, Rich JN, Reardon DA. Sathornsumetee S, et al. Neurol Clin. 2007 Nov;25(4):1111-39, x. doi: 10.1016/j.ncl.2007.07.004. Neurol Clin. 2007. PMID: 17964028 Review.
ALS Untangled No. 20: the Deanna protocol.
ALSUntangled Group; Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E. ALSUntangled Group, et al. Among authors: sathornsumetee s. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23638638 Review. No abstract available.
Brainstem dysfunction heralding disseminated cryptococcosis.
Srivanitchapoom P, Pitakpatapee Y, Sitthinamsuwan P, Sathornsumetee S. Srivanitchapoom P, et al. Among authors: sathornsumetee s. Clin Neurol Neurosurg. 2018 Apr;167:62-64. doi: 10.1016/j.clineuro.2018.02.015. Epub 2018 Feb 12. Clin Neurol Neurosurg. 2018. PMID: 29454181
Designer therapies for glioblastoma multiforme.
Sathornsumetee S, Rich JN. Sathornsumetee S, et al. Ann N Y Acad Sci. 2008 Oct;1142:108-32. doi: 10.1196/annals.1444.009. Ann N Y Acad Sci. 2008. PMID: 18990124 Review.
Molecularly targeted therapy for malignant glioma.
Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Sathornsumetee S, et al. Cancer. 2007 Jul 1;110(1):13-24. doi: 10.1002/cncr.22741. Cancer. 2007. PMID: 17520692 Free article. Review.
Targeting multiple kinases in glioblastoma multiforme.
Sathornsumetee S, Reardon DA. Sathornsumetee S, et al. Expert Opin Investig Drugs. 2009 Mar;18(3):277-92. doi: 10.1517/13543780802692603. Expert Opin Investig Drugs. 2009. PMID: 19243279 Review.
Neurofibromatosis type 2.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Sathornsumetee S, et al. Neurology. 2007 Mar 27;68(13):E14. doi: 10.1212/01.wnl.0000257828.56178.9f. Neurology. 2007. PMID: 17389295 No abstract available.
61 results